NMOSD

Clinical trials for NMOSD explained in plain language.

Never miss a new study

Get alerted when new NMOSD trials appear

Sign up with your email to follow new studies for NMOSD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet recruiting 3 Not yet finished but already full! 1

New hope for NMOSD: drug aims to slash relapse rate in chinese patients

Disease control Ongoing

This study tests eculizumab in 21 Chinese adults with a severe autoimmune disease called NMOSD that attacks the nerves. The goal is to see if the drug can reduce the number of relapses and slow disability. Participants must already be on stable immunosuppressant medication, which…

Matched conditions: NMOSD

Phase: PHASE3 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control

Last updated May 14, 2026 12:04 UTC

NMOSD

Get alerted when new NMOSD trials appear

New hope for NMOSD: drug aims to slash relapse rate in chinese patients